全球血流感染检测市场 - 行业趋势和 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球血流感染检测市场 - 行业趋势和 2028 年预测

  • Healthcare
  • Upcoming Report
  • Nov 2024
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Bloodstream Infection Testing Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2025 –2032
Diagram Market Size (Base Year)
USD 1.20 Billion
Diagram Market Size (Forecast Year)
USD 1.87 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

全球血流感染检测市场,按产品(消耗品、仪器和软件)、技术(传统、PCR 方法、核酸检测、质谱 POC 检测)、技术(基于培养、分子蛋白质组学)、应用(医院获得性、基于社区)、类型(细菌、真菌和分枝杆菌)、最终用户(医院、医疗中心、实验室、独立诊断中心、研究或学术机构)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2028 年。

血流感染检测市场

市场分析与洞察:全球血流感染检测市场

全球血流感染检测市场预计将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析该市场规模将从 2020 年的 9.5943 亿美元增长到 2028 年的 15.017 亿美元,在上述预测期内的复合年增长率为 5.76%。

血液感染检测是医疗中心、医院或实验室提供的血液感染检测服务。检测的主要目的是检测引起血液感染的细菌或生物。

全球范围内对传染病艾滋病毒、肺炎和癌症)的认识不断提高,预计这将推动市场的增长,因为这些疾病需要在选定的时间间隔内进行血液检测。另一个在推动市场增长方面发挥重要作用的潜在因素是不同市场参与者为增强有效检测设备而进行的技术进步。目前已建立的市场参与者在医疗工具领域的进步主要集中在不断升级技术,例如多功能自动化机器,以提高提供给患者的医疗设备的质量。

然而,欠发达国家缺乏与医疗检测相关的适当医疗设施、诊断成本高以及投资低,这些都成为市场增长的阻碍。在预测期内,引入新的成本效益高且易于使用的设备可能会带来新的机会。严格的监管环境和严格的报销政策可能会成为市场面临的重大挑战。

This bloodstream infection testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research bloodstream infection testing market contact us for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bloodstream Infection Testing Market Scope and Market Size

The bloodstream infection testing market is segmented on the basis of product, technique, technology, application, type and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • On the basis of product, the bloodstream infection testing market is segmented into consumables, instruments and software.
  • Based on technique, the bloodstream infection testing market is segmented into conventional, PCR methods, nucleic acid testing, mass spectroscopy and POC testing.
  • On the basis of technology, the bloodstream infection testing market is bifurcated into culture-based and molecular proteomic.
  • On the basis of application, the bloodstream infection testing market is segregated into hospital acquired and community based.
  • On the basis of type, the bloodstream infection testing market is segmented into bacterial, fungal and mycobacterial.
  • On the basis of by end user, the market is segregated into hospitals, healthcare centers, laboratories, independent diagnostic centers, independent diagnostic centers and research/academic institutes.

Bloodstream Infection Testing Market Country Level Analysis

Bloodstream infection testing market is analyzed and market size insights and trends are provided by product, technique, technology, application, type and end user as referenced above.

The countries covered in the bloodstream infection testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

The dominating region in the bloodstream infection testing market is North America due to its availability of high amount of demand of respective testing instruments in hospitals for increasing number of cases related to sepsis, chronic diseases, HIV, pneumonia, and infections. Moreover, the proper availability of healthcare and the medical facilities are also major factors which make this region the most dominant. On the other hand, Asia-Pacific region is emerging as a lucrative market as it is projected to register the highest CAGR within the forecast period of 2021 to 2028 due to the increasing awareness, large population and developing healthcare infrastructure and other medical investments.

The country section of the bloodstream infection testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Bloodstream infection testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for bloodstream infection testing Market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the bloodstream infection testing Market. The data is available for historic period of 2010 to 2019.

Competitive Landscape and Global Bloodstream Infection Testing Market Share Analysis

The bloodstream infection testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bloodstream infection testing Market.

血液感染检测市场报告中涉及的主要参与者包括 Thermo Fisher Scientific Inc.、F. Hoffmann-La Roche Ltd、Abbott、BD、bioMérieux SA、Beckman Coulter, Inc.、Babson Diagnostics、Diazyme Laboratories, Inc.、Cepheid、Luminex Corporation、Accelerate Diagnostics, Inc.、InBios International, Inc.、Ortho Clinical Diagnostics、OpGen、Bruker、Grifols SA GmbH 和 Danaher 等国内和国际参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The market is segmented based on Segmentation, By Product (Consumables, Instruments, and Software),Technique (Conventional, PCR Methods, Nucleic Acid Testing, Mass Spectroscopy, and POC Testing),Technology (Culture-based and Molecular Proteomic), Application (Hospital Acquired and Community Based), Type (Bacterial, Fungal, and Mycobacterial), End User (Hospitals, Healthcare Centers, Laboratories, Independent Diagnostic Centers, and Research or Academic Institutes) – Industry Trends and Forecast to 2032 .
The Global Bloodstream Infection Testing Market size was valued at USD 1.20 USD Billion in 2024.
The Global Bloodstream Infection Testing Market is projected to grow at a CAGR of 5.76% during the forecast period of 2025 to 2032.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.